Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 558

1.

Population Serologic Immunity to human and avian H2N2 viruses in the United States and Hong Kong for Pandemic Risk Assessment.

Babu TM, Perera R, Wu JT, Fitzgerald T, Nolan C, Cowling BJ, Krauss S, Treanor JT, Peiris M.

J Infect Dis. 2018 May 12. doi: 10.1093/infdis/jiy291. [Epub ahead of print]

PMID:
29762672
2.

Association Between Facility-Level Utilization of Non-pharmacologic Chronic Pain Treatment and Subsequent Initiation of Long-Term Opioid Therapy.

Carey EP, Nolan C, Kerns RD, Ho PM, Frank JW.

J Gen Intern Med. 2018 May;33(Suppl 1):38-45. doi: 10.1007/s11606-018-4324-y.

PMID:
29633137
3.

Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.

Kurozumi S, Joseph C, Sonbul S, Gorringe KL, Pigera M, Aleskandarany MA, Diez-Rodriguez M, Nolan CC, Fujii T, Shirabe K, Kuwano H, Storr S, Martin SG, Ellis IO, Green AR, Rakha EA.

Breast Cancer Res Treat. 2018 Apr 9. doi: 10.1007/s10549-018-4777-z. [Epub ahead of print]

PMID:
29633055
4.

Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation.

O'Neill BT, Beck EM, Butler CR, Nolan CE, Gonzales C, Zhang L, Doran SD, Lapham K, Buzon LM, Dutra JK, Barreiro G, Hou X, Martinez-Alsina LA, Rogers BN, Villalobos A, Murray JC, Ogilvie K, LaChapelle EA, Chang C, Lanyon LF, Steppan CM, Robshaw A, Hales K, Boucher GG, Pandher K, Houle C, Ambroise CW, Karanian D, Riddell D, Bales KR, Brodney MA.

J Med Chem. 2018 Apr 17. doi: 10.1021/acs.jmedchem.8b00246. [Epub ahead of print]

PMID:
29613789
5.

Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.

Joseph C, Macnamara O, Craze M, Russell R, Provenzano E, Nolan CC, Diez-Rodriguez M, Sonbul SN, Aleskandarany MA, Green AR, Rakha EA, Ellis IO, Mukherjee A.

Br J Cancer. 2018 Apr;118(8):1142-1151. doi: 10.1038/s41416-018-0041-x. Epub 2018 Mar 28.

PMID:
29588513
6.

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.

El Ansari R, Craze ML, Miligy I, Diez-Rodriguez M, Nolan CC, Ellis IO, Rakha EA, Green AR.

Breast Cancer Res. 2018 Mar 22;20(1):21. doi: 10.1186/s13058-018-0946-6.

7.

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.

El Ansari R, Craze ML, Diez-Rodriguez M, Nolan CC, Ellis IO, Rakha EA, Green AR.

Br J Cancer. 2018 Apr;118(8):1115-1122. doi: 10.1038/s41416-018-0038-5. Epub 2018 Mar 16.

PMID:
29545595
8.

Barriers to a healthy lifestyle for three- to four-year-old children of Australian-born and overseas-born mothers with post-gestational diabetes: An Australian qualitative study.

Zulfiqar T, Nolan CJ, Banwell C, Young R, Boisseau L, Ingle M, Lithander FE.

J Child Health Care. 2018 Jan 1:1367493518759240. doi: 10.1177/1367493518759240. [Epub ahead of print]

PMID:
29444583
9.

Diabetes in pregnancy: a new decade of challenges ahead.

Schaefer-Graf U, Napoli A, Nolan CJ; Diabetic Pregnancy Study Group.

Diabetologia. 2018 May;61(5):1012-1021. doi: 10.1007/s00125-018-4545-y. Epub 2018 Jan 22. Review.

PMID:
29356835
10.

Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain.

Zhang L, Chen L, Dutra JK, Beck EM, Nag S, Takano A, Amini N, Arakawa R, Brodney MA, Buzon LM, Doran SD, Lanyon LF, McCarthy TJ, Bales KR, Nolan CE, O'Neill BT, Schildknegt K, Halldin C, Villalobos A.

J Med Chem. 2018 Apr 26;61(8):3296-3308. doi: 10.1021/acs.jmedchem.7b01769. Epub 2018 Feb 2.

PMID:
29356535
11.

Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?

Spruit MA, Singh SJ, Rochester CL, Greening NJ, Franssen FME, Pitta F, Troosters T, Nolan C, Vogiatzis I, Clini EM, Man WD, Burtin C, Goldstein RS, Vanfleteren LEGW, Kenn K, Nici L, Janssen DJA, Casaburi R, Shioya T, Garvey C, Carlin BW, ZuWallack RL, Steiner M, Wouters EFM, Puhan MA.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701312. doi: 10.1183/13993003.01312-2017. Print 2018 Jan. No abstract available.

PMID:
29326328
12.

Overview of metastatic disease of the central nervous system.

Nolan C, Deangelis LM.

Handb Clin Neurol. 2018;149:3-23. doi: 10.1016/B978-0-12-811161-1.00001-3.

PMID:
29307359
13.

High mobility group protein B1 is a predictor of poor survival in ovarian cancer.

Machado LR, Moseley PM, Moss R, Deen S, Nolan C, Spendlove I, Ramage JM, Chan SY, Durrant LG.

Oncotarget. 2017 Aug 24;8(60):101215-101223. doi: 10.18632/oncotarget.20538. eCollection 2017 Nov 24.

14.

Reply to Rodrigues et al.: Increasing Physical Activity in Daily Life in Chronic Obstructive Pulmonary Disease: To Solve the Puzzle, Every Piece Counts.

Nolan CM, Maddocks M, Canavan JL, Jones SE, Delogu V, Kaliaraju D, Banya W, Kon SSC, Polkey MI, Man WD.

Am J Respir Crit Care Med. 2018 Apr 15;197(8):1089-1090. doi: 10.1164/rccm.201711-2213LE. No abstract available.

PMID:
29206054
15.

MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.

Craze ML, Cheung H, Jewa N, Coimbra NDM, Soria D, El-Ansari R, Aleskandarany MA, Wai Cheng K, Diez-Rodriguez M, Nolan CC, Ellis IO, Rakha EA, Green AR.

Br J Cancer. 2018 Jan;118(2):258-265. doi: 10.1038/bjc.2017.387. Epub 2017 Nov 23.

PMID:
29169183
16.

Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis.

Nolan CM, Maddocks M, Maher TM, Canavan JL, Jones SE, Barker RE, Patel S, Jacob J, Cullinan P, Man WD.

Respirology. 2018 May;23(5):498-506. doi: 10.1111/resp.13213. Epub 2017 Nov 14.

PMID:
29139195
17.

Standardized programming to reduce the burden of inappropriate therapies in implantable cardioverter defibrillators - Single centre follow up results.

Boles U, Gul EE, Fitzgerald L, Sadiq Ali F, Nolan C, Aldworth-Gaumond K, Redfearn DR, Baranchuk A, Glover B, Simpson C, Abdollah H, Michael KA.

Indian Pacing Electrophysiol J. 2018 Mar - Apr;18(2):56-60. doi: 10.1016/j.ipej.2017.10.010. Epub 2017 Oct 27.

18.

Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients.

Ebili HO, Iyawe VO, Adeleke KR, Salami BA, Banjo AA, Nolan C, Rakha E, Ellis I, Green A, Agboola AOJ.

Mol Diagn Ther. 2018 Feb;22(1):79-90. doi: 10.1007/s40291-017-0302-z.

PMID:
29075961
19.

The impact of involvement on researchers: a learning experience.

Staley K, Abbey-Vital I, Nolan C.

Res Involv Engagem. 2017 Sep 18;3:20. doi: 10.1186/s40900-017-0071-1. eCollection 2017.

20.

Identification of the signals for glucose-induced insulin secretion in INS1 (832/13) β-cells using metformin-induced metabolic deceleration as a model.

Lamontagne J, Al-Mass A, Nolan CJ, Corkey BE, Madiraju SRM, Joly E, Prentki M.

J Biol Chem. 2017 Nov 24;292(47):19458-19468. doi: 10.1074/jbc.M117.808105. Epub 2017 Oct 2.

PMID:
28972173

Supplemental Content

Loading ...
Support Center